The treatment of epithelial ovarian cancer
- PMID: 7889393
- DOI: 10.3322/canjclin.45.2.88
The treatment of epithelial ovarian cancer
Abstract
The treatment and long-term survival of patients with ovarian cancer varies by stage. At present, five-year survival for patients with early-stage disease ranges from 50 to 95 percent, while five-year survival for patients with advanced-stage disease is less than 25 percent. Several new drugs with significant activity in advanced-stage ovarian cancer offer hope for increased long-term survival in the future. This article reviews the current and experimental approaches to the treatment of all stages of ovarian cancer.
Comment in
-
Ovarian cancer.CA Cancer J Clin. 1995 Mar-Apr;45(2):69-70. doi: 10.3322/canjclin.45.2.69. CA Cancer J Clin. 1995. PMID: 7889391 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
